WRF Capital
Seattle, Washingtonwrfseattle.org
Overview
WRF Capital is the venture capital investment arm of the Washington Research Foundation (WRF). It is an early-stage investor focusing on technology-based start-up companies with strong ties to non-profit research institutions in Washington State. The firm's industry focus includes Life Sciences (biotechnology, pharmaceuticals, medical devices, digital health), Information Technology, and Physical Sciences. WRF Capital often acts as the first investor in pre-seed, seed, and Series A rounds and partners with other angel investors and VCs.
Portfolio Companies
14
Website
wrfseattle.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tune Therapeutics | Jan 2025 | Series B | Co-investor |
| Archon Biosciences | Oct 2024 | Seed | Co-investor |
| Talus Bio | Aug 2024 | Seed | Co-investor |
| Outpace Bio | Aug 2024 | Series B | Co-investor |
| Vilya | Jun 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.